5:33 PM
Aug 28, 2013
 |  BC Extra  |  Politics & Policy

FDA says state biosimilar bills 'worrisome'

An FDA spokesperson said the agency does not have a position on any particular state legislation covering the use of biosimilars but that "efforts to undermine trust" in biosimilars are "worrisome and represent a disservice to patients who could benefit from these lower cost treatments." The comment came in a statement after the California Assembly passed a bill that would restrict when pharmacists...

Read the full 295 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >